Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117061 | SCV000151202 | benign | not specified | 2013-07-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117061 | SCV000250357 | benign | not specified | 2014-06-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000253173 | SCV000319378 | benign | Cardiovascular phenotype | 2015-02-03 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
Invitae | RCV000756176 | SCV000556037 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000717774 | SCV000848633 | benign | History of neurodevelopmental disorder | 2015-02-03 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
ARUP Laboratories, |
RCV001811968 | SCV000883903 | benign | not provided | 2020-12-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000117061 | SCV004029216 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing |